Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Traumatic Brain Injury Treatment Market , by Treatment
6.1 Introduction
6.2 Immediate emergency care
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3 Medications
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.1 Diuretics
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.2 Anti-seizure drugs
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.3 Coma-inducing drugs
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.4 Anti-Anxiety Agent
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.5 Anti-Depressants
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.6 Anti-Psychotics
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.7 Analgesic
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.8 Anti-Convulsants,
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3.9 Anti-Coagulants
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4 Surgery
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4.1 Removing clotted blood (hematomas)
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4.2 Repairing skull fractures
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4.3 Bleeding in the brain
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4.5 Opening a window in the skull
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4.6 Rehabilitation
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
Chapter 7. Global Traumatic Brain Injury Treatment Market , by End-User
7.1 Introduction
7.2 Hospitals
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.3 Neurologist
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.4 Independent Pharmacies
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.5 Rehabilitative Center Treatment
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.6 Other
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
Chapter 8. Global Traumatic Brain Injury Treatment Market , by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9 Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Zimmer Biomet
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Neuren Pharmaceuticals Ltd
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Oxygen Biotherapeutics Inc
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 TEVA Pharmaceutical Industries Ltd
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Ischemic
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Grace Laboratories LLC
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Cognosci
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Medicortex
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.7 Amarantus BioScience Holdings
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Aldagen
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.11 NeuroScience Pharmaceuticals
10.91 Overview
10.92 Product Overview
10.93 Financials
10.94 Key Developments
10.95 SWOT Analysis
10.10 Targacept
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.13 BioDirection, Inc
10.13.1 Overview
10.13.2 Product Overview
10.13.3 Financials
10.13.4 Key Developments
10.13.5 SWOT Analysis
10.14 QuesGen Systems, Inc
10.14.1 Overview
10.14.2 Product Overview
10.14.3 Financials
10.14.4 Key Developments
10.14.5 SWOT Analysis
10.15 BrainScope Company, Inc
10.15.1 Overview
10.15.2 Product Overview
10.15.3 Financials
10.15.4 Key Developments
10.15.5 SWOT Analysis
10.16 Neural Analytics, Inc
10.16.1 Overview
10.16.2 Product Overview
10.16.3 Financials
10.16.4 Key Developments
10.16.5 SWOT Analysis
10.17 Oculogica
10.17.1 Overview
10.17.2 Product Overview
10.17.3 Financials
10.17.4 Key Developments
10.17.5 SWOT Analysis
10.18 BrainScope Company, Inc
10.18.1 Overview
10.18.2 Product Overview
10.18.3 Financials
10.18.4 Key Developments
10.18.5 SWOT Analysis
10.19 Silver Creek Pharmaceuticals Inc
10.19.1 Overview
10.19.2 Product Overview
10.19.3 Financials
10.19.4 Key Developments
10.19.5 SWOT Analysis
10.20 Stemedica Cell Technologies Inc
10.20.1 Overview
10.20.2 Product Overview
10.20.3 Financials
10.20.4 Key Developments
10.20.5 SWOT Analysis
10.21 Banayan Biomarkers Inc
10.21.1 Overview
10.21.2 Product Overview
10.21.3 Financials
10.21.4 Key Developments
10.21.5 SWOT Analysis
10.22 Vasopharm GmbH
10.22.1 Overview
10.22.2 Product Overview
10.22.3 Financials
10.22.4 Key Developments
10.22.5 SWOT Analysis
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s View point
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the Traumatic Brain Injury Treatment Market
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Traumatic Brain Injury Treatment Market Synopsis, 2023-2032
Table 2 Global Traumatic Brain Injury Treatment Market Estimates and Forecast, 2023-2032
(USD Million)
Table 3 Global Traumatic Brain Injury Treatment Market , by Region, 2023-2032 (USD Million)
Table 4 Global Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032 (USD Million)
Table 5 Global Traumatic Brain Injury Treatment Market , by End-User, 2023-2032 (USD Million)
Table 6 North America: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032 (USD Million)
Table 7 North America: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032
(USD Million)
Table 8 US: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032 (USD Million)
Table 9 US: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032 (USD Million)
Table 10 Canada: Traumatic Brain Injury Treatment Market ,by Treatment , 2023-2032
(USD Million)
Table 11 Canada: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032
(USD Million)
Table 12 South America: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032 (USD Million)
Table 13 South America: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032 (USD Million)
Table 14 Europe: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032
(USD Million)
Table 15 Europe: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032
(USD Million)
Table 16 Western Europe: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032 (USD Million)
Table 17 Western Europe: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032 (USD Million)
Table 20 Eastern Europe: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032 (USD Million)
Table 19 Eastern Europe: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032 (USD Million)
Table 20 Asia-Pacific: Traumatic Brain Injury Treatment Market , by Treatment , 2023-2032
(USD Million)
Table 21 Asia-Pacific: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032
(USD Million)
Table 22 Middle East & Africa: Traumatic Brain Injury Treatment Market , by Treatment, 2020-2027 (USD Million)
Table 23 Middle East & Africa: Traumatic Brain Injury Treatment Market , by End-User, 2023-2032 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Traumatic Brain Injury Treatment Market
Figure 3 Segmentation Market Dynamics for Global Traumatic Brain Injury Treatment Market
Figure 4 Global Traumatic Brain Injury Treatment Market Share, by Treatment , 2020
Figure 5 Global Traumatic Brain Injury Treatment Market Share, by End-User, 2020
Figure 6 Global Traumatic Brain Injury Treatment Market Share, by Region, 2020
Figure 7 North America: Traumatic Brain Injury Treatment Market Share, by Country, 2020
Figure 8 Europe: Traumatic Brain Injury Treatment Market Share, by Country, 2020
Figure 9 Asia-Pacific: Traumatic Brain Injury Treatment Market Share, by Country, 2020
Figure 10 Middle East & Africa: Traumatic Brain Injury Treatment Market Share, by Country, 2020
Figure 11 Global Traumatic Brain Injury Treatment Market : Company Share Analysis, 2020 (%)
Figure 12 Zimmer Biomet: Key Financials
Figure 13 Zimmer Biomet: Segmental Revenue
Figure 14 Zimmer Biomet: Geographical Revenue
Figure 15 Neuren Pharmaceuticals Ltd: Key Financials
Figure 16 Neuren Pharmaceuticals Ltd: Segmental Revenue
Figure 17 Neuren Pharmaceuticals Ltd: Geographical Revenue
Figure 20 Oxygen Biotherapeutics Inc: Key Financials
Figure 19 Oxygen Biotherapeutics Inc: Segmental Revenue
Figure 20 Oxygen Biotherapeutics Inc: Geographical Revenue
Figure 21 TEVA Pharmaceutical Industries Ltd : Key Financials
Figure 22 TEVA Pharmaceutical Industries Ltd: Segmental Revenue
Figure 23 TEVA Pharmaceutical Industries Ltd : Geographical Revenue
Figure 24 Ischemic: Key Financials
Figure 25 Ischemic: Segmental Revenue
Figure 26 Ischemic. Geographical Revenue
Figure 27 Grace Laboratories LLC: Key Financials
Figure 28 Grace Laboratories LLC: Segmental Revenue
Figure 29 Grace Laboratories LLC: Geographical Revenue
Figure 30 Cognosci: Key Financials
Figure 31 Cognosci: Segmental Revenue
Figure 32 Cognosci: Geographical Revenue
Figure 33 Medicortex: Key Financials
Figure 34 Medicortex: Segmental Revenue
Figure 35 Medicortex: Geographical Revenue
Figure 36 Amarantus BioScience Holdings: Key Financials
Figure 37 Amarantus BioScience Holdings: Segmental Revenue
Figure 38 Amarantus BioScience Holdings: Geographical Revenue
Figure 39 Aldagen: Key Financials
Figure 40 Aldagen: Segmental Revenue
Figure 41 Aldagen: Geographical Revenue
Figure 42 NeuroScience Pharmaceuticals : Key Financials
Figure 43 NeuroScience Pharmaceuticals : Segmental Revenue
Figure 44 NeuroScience Pharmaceuticals : Geographical Revenue
Figure 45 Targacept: Key Financials
Figure 46 Targacept: Segmental Revenue
Figure 47 Targacept: Geographical Revenue
Figure 48 BioDirection, Inc: Key Financials
Figure 49 BioDirection, Inc: Segmental Revenue
Figure 50 BioDirection, Inc: Geographical Revenue
Figure 51 QuesGen Systems, Inc: Key Financials
Figure 52 QuesGen Systems, Inc: Segmental Revenue
Figure 53 QuesGen Systems, Inc: Geographical Revenue
Figure 54 BrainScope Company, Inc, Inc: Key Financials
Figure 55 BrainScope Company, Inc, Inc: Segmental Revenue
Figure 56 BrainScope Company, Inc, Inc: Geographical Revenue
Figure 57 Neural Analytics, Inc, Inc: Key Financials
Figure 58 Neural Analytics, Inc, Inc: Segmental Revenue
Figure 59 Neural Analytics, Inc, Inc: Geographical Revenue
Figure 60 Oculogica, Inc: Key Financials
Figure 61 Oculogica, Inc: Segmental Revenue
Figure 62 Oculogica, Inc: Geographical Revenue
Figure 63 BrainScope Company, Inc: Key Financials
Figure 64 BrainScope Company, Inc: Segmental Revenue
Figure 65 BrainScope Company, Inc: Geographical Revenue
Figure 66 Silver Creek Pharmaceuticals Inc: Key Financials
Figure 67 Silver Creek Pharmaceuticals Inc: Segmental Revenue
Figure 68 Silver Creek Pharmaceuticals Inc: Geographical Revenue
Figure 69 Stemedica Cell Technologies Inc: Key Financials
Figure 70 Stemedica Cell Technologies Inc: Segmental Revenue
Figure 71 Stemedica Cell Technologies Inc: Geographical Revenue
Figure 72 Banayan Biomarkers Inc: Key Financials
Figure 73 Banayan Biomarkers Inc: Segmental Revenue
Figure 74 Banayan Biomarkers Inc: Geographical Revenue
Figure 75 Vasopharm GmbH: Key Financials
Figure 76 Vasopharm GmbH: Segmental Revenue
Figure 77 Vasopharm GmbH: Geographical Revenue
